dc.contributor.author | Nejabati, HR | |
dc.contributor.author | Mota, A | |
dc.contributor.author | Farzadi, L | |
dc.contributor.author | Ghojazadeh, M | |
dc.contributor.author | Fattahi, A | |
dc.contributor.author | Hamdi, K | |
dc.contributor.author | Nouri, M | |
dc.date.accessioned | 2018-08-26T08:55:39Z | |
dc.date.available | 2018-08-26T08:55:39Z | |
dc.date.issued | 2017 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/54333 | |
dc.description.abstract | Purpose: Considering potential roles of soluble receptor for advanced glycation end products (sRAGE) and placental growth factor (PlGF) in ovarian function and embryo implantation, in the present study we have evaluated the association of these factors and also PlGF/sFlt-1 ratio with the ovarian response and implantation rate by dividing patients according to the OSI. Methods: In a cross-sectional study, 90 infertile women who were undergoing ICSI cycle using long protocol were recruited. The patients were divided according to ovarian sensitivity index (OSI). ICSI cycle outcomes were evaluated for each patient and PlGF, sFlt-1 and sRAGE levels of follicular fluid were assayed using commercial ELISA kits. Results: Follicular fluid (FF) sRAGE levels and PlGF/sFlt-1 ratio were statistically greater in high-responder women than other responders (pأ¯?آ½<أ¯?آ½0.05). Positive correlations were obtained between sRAGE level with the number of oocytes, follicles and OSI level. sRAGE levels with cutoff value of 4.83 (ng/ml) for evaluating the pregnancy outcome showed 81.8أ¯?آ½% sensitivity and 60.7أ¯?آ½% specificity. Furthermore, there were positive associations between PlGF/sFlt-1 ratio with the number of oocytes, embryos and OSI level. Conclusion: In conclusion, the results of current study supported that good ovarian response is independent of pregnancy outcome. Our results showed that FF levels of sRAGE and PlGF/sFlt-1 ratio could be used as markers for determining the high-responder women. Also, FF sRAGE levels could be a good predictor for ART outcome. أ¯?آ½ 2016, Italian Society of Endocrinology (SIE). | |
dc.language.iso | English | |
dc.relation.ispartof | Journal of Endocrinological Investigation | |
dc.subject | advanced glycation end product receptor | |
dc.subject | placental growth factor | |
dc.subject | protein tyrosine kinase | |
dc.subject | soluble fms like tyrosine kinase 1 | |
dc.subject | unclassified drug | |
dc.subject | advanced glycation end product | |
dc.subject | advanced glycation end product receptor | |
dc.subject | biological marker | |
dc.subject | FLT1 protein, human | |
dc.subject | placental growth factor | |
dc.subject | vasculotropin receptor 1 | |
dc.subject | adult | |
dc.subject | Article | |
dc.subject | controlled study | |
dc.subject | cross-sectional study | |
dc.subject | ELISA kit | |
dc.subject | female | |
dc.subject | female infertility | |
dc.subject | genital system disease assessment | |
dc.subject | human | |
dc.subject | intracytoplasmic sperm injection | |
dc.subject | major clinical study | |
dc.subject | nidation | |
dc.subject | oocyte | |
dc.subject | ovarian sensitivity index | |
dc.subject | ovary follicle fluid | |
dc.subject | pregnancy outcome | |
dc.subject | sensitivity and specificity | |
dc.subject | chemistry | |
dc.subject | cytology | |
dc.subject | follow up | |
dc.subject | in vitro fertilization | |
dc.subject | Infertility, Female | |
dc.subject | male | |
dc.subject | metabolism | |
dc.subject | ovary | |
dc.subject | ovary follicle fluid | |
dc.subject | pathophysiology | |
dc.subject | physiology | |
dc.subject | pregnancy | |
dc.subject | procedures | |
dc.subject | prognosis | |
dc.subject | young adult | |
dc.subject | Adult | |
dc.subject | Advanced Glycosylation End Product-Specific Receptor | |
dc.subject | Biomarkers | |
dc.subject | Cross-Sectional Studies | |
dc.subject | Female | |
dc.subject | Fertilization in Vitro | |
dc.subject | Follicular Fluid | |
dc.subject | Follow-Up Studies | |
dc.subject | Glycosylation End Products, Advanced | |
dc.subject | Humans | |
dc.subject | Infertility, Female | |
dc.subject | Male | |
dc.subject | Oocytes | |
dc.subject | Ovary | |
dc.subject | Placenta Growth Factor | |
dc.subject | Pregnancy | |
dc.subject | Prognosis | |
dc.subject | Vascular Endothelial Growth Factor Receptor-1 | |
dc.subject | Young Adult | |
dc.title | Follicular fluid PlGF/sFlt-1 ratio and soluble receptor for advanced glycation end-products correlate with ovarian sensitivity index in women undergoing A.R.T | |
dc.type | Article | |
dc.citation.volume | 40 | |
dc.citation.issue | 2 | |
dc.citation.spage | 207 | |
dc.citation.epage | 215 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.1007/s40618-016-0550-5 | |